Thinking of joining a study?

Register your interest

NCT06627894 | NOT YET RECRUITING | Depression


Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)
Sponsor:

Indiana University

Information provided by (Responsible Party):

Babar Khan, MD, MS

Brief Summary:

Depression affects one-third of intensive care unit (ICU) survivors and represents a potentially modifiable target to slow cognitive decline and reduce the risk of Alzheimer's disease and related dementias (ADRD). Our multi-PI team proposes a two-arm RCT called ADEPT-ICU (Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors), which will test the efficacy of an internet CBT intervention called Good Days Ahead (GDA) to reduce the burden of subjective cognitive decline (SCD) in older ICU survivors with moderate to severe depressive symptoms after ICU hospitalization.

Condition or disease

Depression

Cognitive Decline

Intervention/treatment

Therapist-Assisted Internet Cognitive-Behavioral Therapy for Depression

Active Control

Phase

NA

Detailed Description:

Alzheimer's disease and related dementias (ADRD) affect 47 million people worldwide with an annual global cost of $818 billion. The risk of developing ADRD is disproportionately borne by older adults with multiple chronic conditions from underrepresented racial and ethnic groups (URGs). One such high risk group is older survivors of critical illness who were admitted to the intensive care units (ICUs). Nearly half of ICU survivors experience subjective cognitive decline(SCD), i.e., perceived decline in memory and thinking even with normal objective cognitive data. With over 5 million adult ICU admissions in the US each year, an intervention reducing SCD in older ICU survivors could significantly prevent or lower the incidence of ADRD. Thus, there is an urgent need for an inclusive randomized controlled trial (RCT) to rigorously test whether a novel, accessible, and scalable intervention can reduce SCD in a diverse cohort of older ICU survivors. One potential target for such interventions is post-ICU depression, which affects about one-third of ICU survivors. To date, there are no large scale RCTs which have rigorously tested whether depression focused psychotherapies, such as cognitive behavioral therapy (CBT), reduce SCD in a diverse cohort of older ICU survivors with depression. We propose a two-arm, randomized, parallel-group, assessor-blinded clinical trial to evaluate the efficacy of internet CBT for depression compared to an active control in reducing SCD and slowing cognitive decline in older ICU survivors with post-ICU depression. The total duration of the intervention will be 6 months from randomization.

Study Type : INTERVENTIONAL
Estimated Enrollment : 300 participants
Masking : DOUBLE
Masking Description : The unblinded study coordinator is aware of randomization. The investigator and study team members responsible for the delivery of the intervention will be unblinded. The study team staff performing outcomes assessments and the investigators overseeing this process will be blinded.
Primary Purpose : TREATMENT
Official Title : Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)
Actual Study Start Date : 2024-12-15
Estimated Primary Completion Date : 2029-10-30
Estimated Study Completion Date : 2029-10-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. 50 years of age and older
  • 2. Admitted to the intensive care for greater \> 48 hours
  • 3. Able to understand and provide informed consent
  • 4. Validated depression diagnosis (PHQ-9 \> 10)
  • 5. Willing to participate in cognitive testing
  • 6. Access to a telephone
  • 7. Discharge to home or an independent or assisted living facility
Exclusion Criteria
  • 1. Diagnosis of dementia or neurodegenerative disease (e.g. Alzheimer's disease, vascular dementia as per EHR and IQCODE, or Parkinson's disease) or on anti-dementia medications prior to ICU stay
  • 2. Diagnosis of severe mental illness (bipolar disorder, schizophrenia, schizoaffective) as per EHR and screening questions
  • 3. Persistent psychotic symptoms after ICU stay which would interfere with successful completion of intervention
  • 4. Recent or recurrent alcohol or substance use disorder as per HER and Drug Abuse Screening Test
  • 5. Life expectancy less than 1 year (e.g. terminal cancer diagnosis, discharged on hospice)
  • 6. Ischemic or hemorrhagic stroke, traumatic brain injury, or undergoing neurosurgery prior, during or after ICU stay
  • 7. Uncorrected visual or auditory impairment including legal blindness or deaf
  • 8. Status post tracheostomy and not able to communicate
  • 9. Incarcerated or on parole after ICU stay

Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)

Location Details

NCT06627894


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Indiana

Eskenazi Hospital

Indianapolis, Indiana, United States, 46202

Not yet recruiting

United States, Indiana

IU Health Methodist Hospital

Indianapolis, Indiana, United States, 46202

Loading...